The Trump administration should take specific steps to reduce the regulatory burden on hospitals, an industry group said in a May 17 letter to Health and Human Services Secretary Tom Price.
The Federation of American Hospitals, which represents investor-owned hospitals, called for changes in numerous areas, including suspending the hospital quality ratings system and readjusting bundled payment programs. Other hospital groups have asked the administration for similar actions in recent months.
Ivy Baer, senior director and regulatory counsel at the Association of American Medical Colleges, told me she agreed with the FAH’s recommendation for a new hospital ratings system, and that, “the info in the current rating system doesn’t give patients the best knowledge to make the best decisions.” Under the current system, hospitals are given between one and five stars depending on how well they scored on dozens of quality measures, such as emergency room waiting times.
The FAH’s letter cited the Feb. 24 executive order by President Donald Trump, ordering a reduction in “unnecessary regulatory burdens placed on the American people.”
Lisa Tofil, an attorney at Holland & Knight in Washington, told me the Trump administration has been very open and receptive to input from the hospital sector. “It seems they really welcome people’s ideas on how to improve efficiency and reduce costs,” she said. “Any regulatory relief that could be provided would be helpful, especially from the provider side.”
The FAH also recommended the CMS permanently end the controversial home-health demonstration, a program intended to reduce home-health fraud in states that have historically seen high levels of fraud.
William Dombi, vice president for law at the National Association for Home Care and Hospice, told me that ending the home-health pre-claim “would save Medicare a few hundred million dollars.” Dombi is a Bloomberg BNA advisory board member.
Read my full article here.
Stay on top of new developments in health law and regulation with a free trial to the Health Law Resource Center.
Learn more about Bloomberg Law and sign up for a free trial.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)